摘要
目的探讨两种不同药物在急性ST段抬高型心肌梗死疾病治疗中的临床运用效果。方法按随机数字表法,将我院所收治的78例急性ST段抬高型心肌梗死患者均分成实验组与对照组,在常规治疗的基础之上,对照组给予尿激酶,实验组给予瑞替普酶,且比较两组患者的治疗效果。结果经治疗后,实验组有效率为92.3%,高于对照组的69.2%,P<0.05,差异具有统计学意义。结论对急性st段抬高型心肌梗死患者予以瑞替普酶药物治疗,效果显著,且不良反应发生率低。
Objective To investigate the clinical effect of two different drugs in the treatment of acute ST segment elevation myocardial infarction. Methods According to the randomly number table method, selceted 78 patients with acute ST segment elevation myocardial infarction patients admitted in our hospital, were divided into the experimental group and the control group, on the basis of routine treatment, patients in control group were treated with urokinase, the patients in the experimental group be reteplase, and therapeutic effect were compared between the two groups. Results After treatment. The effective rate of the experimental group was 92.3%, higher than the control group 69.2%,P〈0.05, was difference had statistically significance.Conclusion In patients with acute ST segment elevation myocardial infarction treated with simvastatin, the effect is significant, and the incidence of adverse reactions is low.
出处
《中国继续医学教育》
2015年第31期150-151,共2页
China Continuing Medical Education
关键词
急性ST段抬高型心肌梗死
瑞替普酶
效果
ST segment elevation acute myocardial infarction
Reteplase
Effect
